EarthLab Inc Recall: The microbial test result is found to be out of specification due to high yeast and mold counts.

🇺🇸 United States

1. May 11, 2022 - Recall initiated
2. June 29, 2022 - Reported by source
3. May 22, 2023 - Recall terminated

Official source record

Agency

FDA

Dataset

FDA Food Enforcement (Recalls)

Recall number

F-1346-2022

Event ID

90203

Status

Terminated

Classification

Class II

Company

EarthLab Inc

Product description

Wise Woman Herbals Kava Capsules, 450 mg Kava (Piper met. Root), Dosage: 1 capsule up to 3 times per day day at 450mg Kava root. 90 counts per bottle. UPC 7 48840 14284 8. Kava Capsules older lots are packaged in 250cc Wide Mouth Amber Glass Packer, Black 45/400 PP ribbed skirt screw-top lid, clear neck band, Wise Woman Herbals Large botanical label. Kava Capsules newer lots are packaged in White polypropylene packer style bottle, White serrated flat-topped lid with foam liner, clear neckband, Wise Woman Herbals label.

Quantity

1,213 units

Reason

The microbial test result is found to be out of specification due to high yeast and mold counts.

Recall initiation date

May 11, 2022

Report date

June 29, 2022

Classification date

Not published in this source record

Termination date

May 22, 2023

Distribution pattern

nationwide

UPC, lot, and code information

90KACA (90 indicates package size; KA indicates Kava; CA indicates capsule). Lots: 16754, 17157, and 17764-1. Best Used By for each lot: 10/22/21 (for 16754); 10/22/22 (for 17157); 1/26/24 (for 17764-1).

Voluntary or mandated

Voluntary: Firm initiated

Initial notification method

Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Source last updated

Not tracked separately from the Public Health Trace retrieval date below

Public Health Trace retrieval date

July 18, 2026 ET

Other products recalled under this same event

This recall shares FDA event ID 90203 with 2 other product entries in Public Health Trace.

Responsible company: EarthLab Inc

Other recalls from EarthLab Inc

Where this information comes from

View FDA enforcement record -- the specific openFDA record this summary was built from.

No separate FDA public notice was found for this enforcement record. The information below comes from FDA's Recall Enterprise System through openFDA.

FDA Enforcement Reports -- FDA's general, official recall and enforcement information.

Technical source data

View raw source data -- the machine-readable record this page's information was built from.

Retrieved by Public Health Trace: July 18, 2026 ET

Frequently asked questions

What does a Class II mean?

A situation in which use of or exposure to a product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote.

Is this recall still active?

According to FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.

What should I do if I have this product?

Follow the instructions published by the responsible agency (see the source links below) -- recall guidance (e.g. dispose of the product, return it for a refund, or check for a specific lot number) varies by recall and is set by that agency, not by Public Health Trace.

Where can I find more official information?

The source links below, published by FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.

This summary is based on the official source record referenced above. Public Health Trace does not state that any company or product is unsafe beyond what the official source has published. Read the full medical disclaimer.

• Email
• X / Twitter
• Facebook